Soleno Therapeutics Inc (SLNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,238 | -3,707 | -6,482 | N/A | N/A |
| Depreciation Amortization | 29 | 42 | 44 | N/A | N/A |
| Accounts receivable | 150 | -150 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 354 | -162 | 46 | N/A | N/A |
| Other Working Capital | 300 | -226 | 29 | N/A | N/A |
| Other Operating Activity | 7,921 | 3,317 | 2,867 | 0 | 0 |
| Operating Cash Flow | $-4,484 | $-885 | $-3,496 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -31 | -1 | -3 | N/A | N/A |
| Investing Cash Flow | $-31 | $-1 | $-3 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,591 | N/A | 4,999 | N/A | N/A |
| Common Stock Issued | 10,728 | N/A | 28 | N/A | N/A |
| Other Financing Activity | -2,115 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $11,203 | $N/A | $5,027 | $N/A | $N/A |
| Beginning Cash Position | 1,269 | 2,155 | 627 | N/A | N/A |
| End Cash Position | 7,957 | 1,269 | 2,155 | N/A | N/A |
| Net Cash Flow | $6,688 | $-887 | $1,528 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,484 | -885 | -3,496 | N/A | N/A |
| Capital Expenditure | -31 | -1 | -3 | N/A | N/A |
| Free Cash Flow | -4,515 | -887 | -3,499 | 0 | 0 |